CYTEK BIOSCIENCES, INC. (CTKB) Overview
- 1 Jul 2022: Period ending 30 Sept 2022; Estimate (m); Actual -0.01; Beat / miss (m).
- 1 Apr 2022: Period ending 30 Jun 2022; Estimate (m); Actual 0.00; Beat / miss (m).
- 1 Jan 2022: Period ending 31 Mar 2022; Estimate (m); Actual 0.02; Beat / miss (m).
- 1 Jul 2021: Period ending 30 Sept 2021; Estimate (m); Actual 0.00; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $5.85
- Previous close
- $5.76
- Change
- $0.09
- Change (%)
- 1.56%
- Close date
- 2026-11-06
- Previous close date
- 2026-09-29
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- CTKB
- +14.06%
- S&P 500
- (m)
1 year
- CTKB
- +70.41%
- S&P 500
- (m)
3 years
- CTKB
- +4.35%
- S&P 500
- (m)
5 years
- CTKB
- -72.52%
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
30 Sept 2022 ○ Estimate (m) ● Actual -0.01
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Jul 2022 | 30 Sept 2022 | (m) | -0.01 | (m) | (m) |
| 1 Apr 2022 | 30 Jun 2022 | (m) | 0.00 | (m) | (m) |
| 1 Jan 2022 | 31 Mar 2022 | (m) | 0.02 | (m) | (m) |
| 1 Jul 2021 | 30 Sept 2021 | (m) | 0.00 | (m) | (m) |
| 1 Apr 2021 | 30 Jun 2021 | (m) | 0.00 | (m) | (m) |
31 Dec 2023 ○ Estimate (m) ● Actual -0.09
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Jan 2023 | 31 Dec 2023 | (m) | -0.09 | (m) | (m) |
| 1 Jan 2022 | 31 Dec 2022 | (m) | 0.02 | (m) | (m) |
| 1 Jan 2021 | 31 Dec 2021 | (m) | 0.00 | (m) | (m) |
| 1 Jan 2020 | 31 Dec 2020 | (m) | 0.10 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
30 Jun 2026 ■ Revenue 48.14M ■ Earnings -12.16M — Profit margin -25.26%
31 Dec 2025 ■ Revenue 201.49M ■ Earnings -66.54M — Profit margin -33.02%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $5.85 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning CTKB
View more →(m)
Statistics
View more →Retained observations as of 2026-11-11; financial period ending (m).
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- (m)
- Profit margin
- (m)
- Return on assets · 12 month
- (m)
- Stock compensation expense · all employees · 12 months
- (m)
- Named executive and board stock awards · latest fiscal year
- (m)
- Index membership
- (m)
- Employees
- 702.00
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 1.32M
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- 0.88%*
- Total return · month
- 23.08%*
- Total return · quarter
- 32.72%*
- Total return · half year
- 33.33%*
- Total return · year to date
- 14.06%*
- Total return · 1 year
- 70.41%*
- Total return · 3 years
- 4.35%*
- Total return · 5 years
- -72.52%*
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- (m)
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
CYTEK BIOSCIENCES, INC. Overview
View more →(m)
(m)
- SEC CIK
- 1831915
- Industry (SIC)
- 3826 Laboratory Analytical Instruments
- Country of operation
- United States
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, California, 94538, United States
- Fiscal year end
- 1231
- Phone
- (877) 922-9835
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |